4//SEC Filing
Santos da Silva Jorge 4
Accession 0001213900-24-016544
CIK 0001821586other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:48 PM ET
Size
5.3 KB
Accession
0001213900-24-016544
Insider Transaction Report
Form 4
Santos da Silva Jorge
DirectorChief Executive Officer
Transactions
- Sale
Class A ordinary shares, par value $0.0001 per share
2024-02-21$55.27/sh−1,125$62,179→ 3,106,429 total
Footnotes (2)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 17, 2023.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.025 to $55.33. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920509
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:48 PM ET
- Size
- 5.3 KB